AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.92
+0.14
(+1.05%)
Pre-Market: 08:22
AbCellera Biologics Total Assets (Quarterly) : 1.308B for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.308B |
| March 31, 2026 | 1.307B |
| December 31, 2025 | 1.357B |
| September 30, 2025 | 1.356B |
| June 30, 2025 | 1.402B |
| March 31, 2025 | 1.344B |
| December 31, 2024 | 1.361B |
| September 30, 2024 | 1.393B |
| June 30, 2024 | 1.412B |
| March 31, 2024 | 1.463B |
| December 31, 2023 | 1.488B |
| September 30, 2023 | 1.512B |
| June 30, 2023 | 1.537B |
| Date | Value |
|---|---|
| March 31, 2023 | 1.498B |
| December 31, 2022 | 1.541B |
| September 30, 2022 | 1.552B |
| June 30, 2022 | 1.594B |
| March 31, 2022 | 1.592B |
| December 31, 2021 | 1.319B |
| September 30, 2021 | 1.173B |
| June 30, 2021 | 1.152B |
| March 31, 2021 | 1.129B |
| December 31, 2020 | 1.006B |
| September 30, 2020 | 142.39M |
| June 30, 2020 | 155.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| MindWalk Holdings Corp. | 12.35M |
| Repligen Corp. | 2.950B |
| Bio-Techne Corp. | 2.679B |
| Aurinia Pharmaceuticals, Inc. | 792.26M |
| BioLife Solutions, Inc. | 447.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 233.30M |
| Shareholders Equity (Quarterly) | 896.02M |
| Debt to Equity Ratio | 0.1514 |
| Current Ratio | 12.77 |
| Net Debt Paydown Yield | -0.56% |